Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
TELA Bio ( (TELA) ) just unveiled an announcement.
On November 13, 2025, TELA Bio, Inc. entered into a Credit Agreement with Perceptive Credit Holdings V, LP, for a senior secured term loan facility of up to $70 million, with an initial $60 million loan funded on November 14, 2025. This agreement, which includes warrants for common stock, aims to enhance the company’s financial flexibility and support its operational growth. Additionally, TELA Bio announced a registered direct offering of common stock and pre-funded warrants, expected to close on November 17, 2025, with net proceeds of approximately $11.9 million intended for general corporate purposes. This financial maneuvering is likely to impact the company’s market positioning by providing necessary capital for expansion and operational needs.
The most recent analyst rating on (TELA) stock is a Hold with a $1.25 price target. To see the full list of analyst forecasts on TELA Bio stock, see the TELA Stock Forecast page.
Spark’s Take on TELA Stock
According to Spark, TipRanks’ AI Analyst, TELA is a Underperform.
TELA Bio’s overall stock score is primarily impacted by its financial performance and technical analysis. Despite revenue growth, the company faces significant profitability and cash flow challenges. Technical indicators show bearish momentum, and the negative P/E ratio suggests overvaluation. The positive aspects from the earnings call are overshadowed by these financial and technical difficulties.
To see Spark’s full report on TELA stock, click here.
More about TELA Bio
TELA Bio, Inc. operates in the medical technology industry, focusing on the development and commercialization of innovative tissue reinforcement materials for soft tissue reconstruction. The company primarily serves the healthcare sector, offering products that address unmet clinical needs in hernia repair, plastic and reconstructive surgery, and other related fields.
Average Trading Volume: 98,151
Technical Sentiment Signal: Strong Sell
Current Market Cap: $45.16M
For a thorough assessment of TELA stock, go to TipRanks’ Stock Analysis page.